<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>multi-institutional clinical research &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/multi-institutional-clinical-research/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 23 Sep 2025 23:22:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>multi-institutional clinical research &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Sylvester Joins $16M National Initiative on AI for Breast Cancer Screening</title>
		<link>https://bioengineer.org/sylvester-joins-16m-national-initiative-on-ai-for-breast-cancer-screening/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 23 Sep 2025 23:21:52 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[AI in breast cancer screening]]></category>
		<category><![CDATA[artificial intelligence in healthcare]]></category>
		<category><![CDATA[Breast Cancer Screening]]></category>
		<category><![CDATA[mammography accuracy improvement]]></category>
		<category><![CDATA[Medical Research Funding]]></category>
		<category><![CDATA[multi-institutional clinical research]]></category>
		<category><![CDATA[Multi-Institutional Clinical Trials]]></category>
		<category><![CDATA[Patient-Centered Outcomes Research]]></category>
		<category><![CDATA[PRISM Trial]]></category>
		<guid isPermaLink="false">https://bioengineer.org/sylvester-joins-16m-national-initiative-on-ai-for-breast-cancer-screening/</guid>

					<description><![CDATA[In a landmark advancement for breast cancer diagnostics, the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine is spearheading a groundbreaking clinical trial designed to rigorously evaluate the role of artificial intelligence (AI) in mammography interpretation. This multi-institutional endeavor, known as the PRISM Trial (Pragmatic Randomized Trial of Artificial Intelligence [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">271590</post-id>	</item>
	</channel>
</rss>
